𝔖 Bobbio Scriptorium
✦   LIBER   ✦

918 CLEVUDINE DEMONSTRATES POTENT ANTIVIRAL ACTIVITY IN THE NAIVE CHRONIC HEPATITIS B PATIENTS

✍ Scribed by June Sung Lee; E.T. Park; S.S. Kang; E.S. Gu; J.S. Kim; D.S. Jang; K.S. Lee; Jae-Su Lee; N.H. Park; C.H. Bae; S.K. Baik; B.J. Yu; S.H. Lee; E.J. Lee; S.I. Park; M. Bae; J.W. Shin; J.H. Choi; C. Gu; S.K. Moon; G.J. Chun; J.H. Kim; H.S. Kim; S.K. Choi

Book ID
117377923
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
47 KB
Volume
50
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A 12-week clevudine therapy showed poten
A 12-week clevudine therapy showed potent and durable antiviral activity in HBeAg-positive chronic hepatitis B
✍ Hyo-Suk Lee; Young-Hwa Chung; KwanSik Lee; Kwan Soo Byun; Seung Woon Paik; Joon- πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 390 KB

Clevudine is a nucleoside analog with an unnatural beta-L configuration. In a phase I/II clinical trial, once daily doses ranging from 10 to 200 mg for 28 days were well tolerated, and produced significant antiviral activity. The present study was conducted to assess the degree and durability of the

Twenty-four-week clevudine therapy showe
Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B
✍ Byung Chul Yoo; Ju Hyun Kim; Young-Hwa Chung; Kwan Sik Lee; Seung Woon Paik; Soo πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 314 KB

Clevudine is a pyrimidine analogue with potent and sustained antiviral activity against HBV. The present study evaluated the safety and efficacy of 30 mg clevudine once daily for 24 weeks and assessed the durable antiviral response for 24 weeks after cessation of dosing. A total of 243 hepatitis B e